Organigram Q2 revenue, adj.
BMO Capital Markets analyst Tamy Chen said it was the third straight quarter than Organigram reported a decline in recreational cannabis revenue.
Clever Leaves books US$13M in Series E financingU.S. medical cannabis operator Clever Leaves International announced Tuesday it raised US$14 million in its latest financing round.
DAILY BUZZ13%– The share of Organigram revenue generated by its “Cannabis 2.0” products in the first two months of availability in the Canadian market.
Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new — and controversial — Canadian recreational marijuana industry.